Adjuvanted vs non-adjuvanted flu vaccine in older adults with chronic conditions
Official title: A Comparative Study on the Immunogenicity and Safety of Adjuvanted Versus Non-Adjuvanted Influenza Vaccines in the Elderly
Run by National Taiwan University Hospital · NCT06676644 · Data updated 2026-11-12
This test tries to see if an adjuvanted flu vaccine gives stronger immune protection and similar safety compared with a standard flu shot in people 65 and older who have chronic medical conditions.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 65 Years and up |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | National Taiwan University Hospital Academic / other |
| Locations | 1 site (Taipei) |
| Status | Recruiting |
| Started | November 21, 2024 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | February 24, 2026 |
| Trial ID | NCT06676644 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are people aged 65 or older with at least one chronic medical condition listed in the protocol who have not yet received a flu vaccine this season and have no contraindication to influenza vaccination.
✕Probably not a fit
People with a history of severe reactions to influenza vaccines, a current-season influenza vaccination, or other contraindications would not be eligible and would not receive benefit from this trial.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a one-year randomized controlled trial at National Taiwan University Hospital comparing an adjuvanted quadrivalent influenza vaccine (aIIV4) with a non-adjuvanted quadrivalent vaccine (IIV4) in Taiwanese adults aged 65 and older with chronic conditions. The trial measures humoral immunogenicity, cellular immune responses, and records safety and adverse events following vaccination. Key eligibility requires age 65+ with at least one chronic medical condition and excludes those with contraindications or prior influenza vaccination in the current season. Participants receive a single season vaccine and are followed through the influenza season for immune response and safety outcomes.
Why it matters
Potential benefit: If successful, the adjuvanted vaccine could provide stronger protection against influenza and reduce complications in older adults with chronic health conditions.
How similar studies have gone: Adjuvanted influenza vaccines have shown improved immune responses in older adults in prior studies and are recommended by some public health bodies, though local data in Taiwan remain limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults aged 65 years or above * Presence of at least 1 chronic medical condition associated with increased risk of complicated influenza, including hypertension, chronic obstructive pulmonary disease (group A, B, E), asthma, congestive heart failure (ACC/AHA stage A, B, C, D), coronary arterial disease, diabetes mellitus, chronic liver disease (Child-Pugh score A, B, C) or chronic kidney disease (stage 1\~4), neuromuscular disorders, hematological or solid organ malignancies, recipient of hematopoietic stem cell transplantation or solid organ transplantation. Exclusion Criteria: * Contraindications to influenza vaccination including history of severe adverse event after vaccination, such as anaphylaxis or Guillain-Barré Syndrome, or a severe bleeding tendency * Prior receipt of influenza vaccination during the current flu season. * Determination by the Principal Investigator (PI) that the participant is ineligible for enrollment based on clinical assessment.
Where it's running
-
National Taiwan University Hospital
Taipei, Taiwan Recruiting
Study contacts
- Study coordinator: Jann-Tay Wang Clinical Professor, M. D., Ph.D.
- Email: wangjt1124@ntuh.gov.tw
- Phone: +886-2-2312-3456
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
FluMist versus injected flu shot: immune responses in the nose and lungs of young adults
This trial will see if the FluMist nasal vaccine causes different immune responses in the blood, nose, and lungs than the standard injected flu shot in healthy adults aged 18 to 40.
-
Dignity Therapy for Older Adults in Long-Term Care
This study tests dignity therapy to help people 65 and older in long-term care see their lives as meaningful and preserve their sense of self.
-
Intravenous iron to improve quality of life in older adults after acute coronary syndrome
This trial will try a single dose of intravenous ferric carboxymaltose in people 65 and older with iron deficiency after an acute coronary event to see if it improves quality of life and reduces frailty and adverse outcomes over 12 months.
-
Continuous monitoring and stepwise control of laryngeal mask airway cuff pressure to reduce throat problems after surgery in older adults
This trial will test whether continuously monitoring and progressively adjusting the inflatable laryngeal mask airway (LMA) cuff pressure reduces postoperative sore throat and swallowing problems in people aged 60 or older having elective non-thoracic, non-head-and-neck surgery.
-
Dynamic versus isometric strength training for older adults with high blood pressure
This project will try dynamic and isometric strength exercises to see if they lower blood pressure and improve mental and muscle health in older adults with hypertension who take blood pressure medication.
-
Predicting function and quality-of-life decline after curative surgery for gastrointestinal cancer in people over 65
This project will try to see which pre- and perioperative factors predict loss of independence and worse quality of life over one year in people aged 65 and older who have curative surgery for gastrointestinal cancers.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.